Clinical Trial Update: Post-Ablation Pericarditis Reduction Study [Phase 2]

View source ↗

Summary

Phase 2 trial update on reducing post-ablation pericarditis in patients undergoing catheter ablation for atrial fibrillation; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: St. Vincent Cardiovascular Research Institute | Conditions: Atrial Fibrillation, Catheter Ablation | Phase 2 | Status: COMPLETED